drugset / Trial / NCT02857010
Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure
Phase 1
Terminated
23 enrolled
Pere Gines
Clinica Universidad de Navarra, Universidad de Navarra · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Double-blind placebo randomized controlled trial evaluating the clinical efficacy of allogenic bone marrow derived mesenchymal stem cells in cirrhotic patients with acute-on-chronic liver failure
Timeline
- Start
- 2016-02
- Primary completion
- 2018-02
- Completion
- 2020-02
Outcome
Outcome not reported
Stopped (Enrollment): “Dificulties to recruit patients and dificulties to obtain MSCs.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allogenic Mesenchymal stem cells | Cell therapy | 2e+06 cells/kg | Intravenous |